Bioten Co., Ltd. (XKON:289170)
South Korea · Delayed Price · Currency is KRW 3,195.00
+10.00 (0.31%)
At close: Apr 17, 2026
Bioten Market Cap
Bioten has a market cap or net worth of 11.43 billion as of April 17, 2026. Its market cap has decreased by -40.61% in one year.
Market Cap
11.43B
Enterprise Value
n/a
Revenue
10.71B
Ranking
n/a
PE Ratio
9.71
Stock Price
3,195.00
Market Cap Chart
Since October 13, 2023, Bioten's market cap has decreased from 23.56B to 11.43B, a decrease of -51.50%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 11.43B | -10.25% |
| Dec 30, 2025 | 12.73B | -29.50% |
| Dec 30, 2024 | 18.06B | 65.39% |
| Dec 28, 2023 | 10.92B | -53.65% |
| Oct 13, 2023 | 23.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seoul Pharma | 33.81B |
| ChoA Pharmaceutical Co., LTD. | 30.17B |
| Daesung Microbiological Labs. | 29.26B |
| Pharmsville | 29.06B |
| Hurum | 25.20B |
| BIFIDO | 24.01B |
| WooGene B&G | 21.93B |
| Union Korea Pharm | 19.70B |